Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Phase I Study of TCD-717 Given by 4-Hour Intravenous Infusion in Patients With Advanced Solid Tumors

NCT01215864 is registered in ClinicalTrials.gov with Traslational Cancer Drugs Pharma, SL as lead sponsor.

NCT NCT01215864
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01215864 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Phase I Study of TCD-717 Given by 4-Hour Intravenous Infusion in Patients With Advanced Solid Tumors
Lead sponsor
Traslational Cancer Drugs Pharma, SL
Phase
Phase 1
Overall status
Completed
Start date
January 31, 2011
Completion date
February 28, 2014
Enrollment
28 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

advanced solid tumors